Metraipolis › archive › dc_8d8956e8aee6

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses — Europe PMC PMID:41251472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41251472
DOI
10.1128/msphere.00722-25
License (as archived)
solo-consultazione
Archived
2026-11-08T11:12:26.956Z
SHA-256 of the archived text
c2b6a8c6f5c427465fcb2fc820df3b21041e77d3e93e01ebc7fd3435e3121dd0
Stable URL of this page
https://metraipolis.com/documento/dc_8d8956e8aee6

How to cite

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses — Europe PMC PMID:41251472 — Europe PMC (en), https://europepmc.org/article/MED/41251472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d8956e8aee6 (Metraipolis archive dc_8d8956e8aee6, sha256 c2b6a8c6f5c427465fcb2fc820df3b21041e77d3e93e01ebc7fd3435e3121dd0)
BibTeX
@misc{dc8d8956e8aee6,
  title = {T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses — Europe PMC PMID:41251472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41251472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d8956e8aee6; sha256 c2b6a8c6f5c427465fcb2fc820df3b21041e77d3e93e01ebc7fd3435e3121dd0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41251472. Agents can read the archived copy with the MCP tool read_document.